AAAAAA

   
Results: 1-9 |
Results: 9

Authors: SLOAND JA SHELLY MA ERENSTONE AL SCHIFF MJ TALLEY TE DHAKAL MP
Citation: Ja. Sloand et al., SAFETY AND EFFICACY OF TOTAL-DOSE IRON DEXTRAN ADMINISTRATION IN PATIENTS ON HOME RENAL REPLACEMENT THERAPIES, Peritoneal dialysis international, 18(5), 1998, pp. 522-527

Authors: SLOAND JA SLOAND EM
Citation: Ja. Sloand et Em. Sloand, STUDIES ON PLATELET MEMBRANE-GLYCOPROTEINS AND PLATELET-FUNCTION DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 8(5), 1997, pp. 799-803

Authors: DHAKAL M SLOAND JA SCHIFF MJ
Citation: M. Dhakal et al., PREVALENCE OF HYPERTENSION (HTN) AND ADEQUACY OF BLOOD-PRESSURE (BP) CONTROL IN HEMODIALYSIS (HD) PATIENTS (PTS) IN THE 90S, Journal of the American Society of Nephrology, 7(9), 1996, pp. 982-982

Authors: SLOAND JA
Citation: Ja. Sloand, LONG-TERM THERAPY FOR UREMIC BLEEDING, International journal of artificial organs, 19(8), 1996, pp. 439-440

Authors: SLOAND JA SCHIFF MJ
Citation: Ja. Sloand et Mj. Schiff, BENEFICIAL EFFECT OF LOW-DOSE TRANSDERMAL ESTROGEN ON BLEEDING-TIME AND CLINICAL BLEEDING IN UREMIA, American journal of kidney diseases, 26(1), 1995, pp. 22-26

Authors: SLOAND JA MEHTA RL SCHMER G ROSENFELD SI
Citation: Ja. Sloand et al., INFLUENCE OF C1Q ON THE INTERACTION OF MODEL IMMUNE-COMPLEXES WITH HUMAN PLATELETS, Clinical immunology and immunopathology, 76(2), 1995, pp. 127-134

Authors: MONK RD FEIGIN AS SLOAND JA
Citation: Rd. Monk et al., RESTLESS LEGS SYNDROME (RLS) IN PATIENTS WITH END-STAGE RENAL-DISEASE(ESRD) - A CASE-CONTROLLED STUDY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 338-338

Authors: SLOAND JA SCHIFF MJ
Citation: Ja. Sloand et Mj. Schiff, BENEFICIAL EFFECT OF LOW-DOSE TRANSDERMAL ESTROGEN ON BLEEDING-TIME (BT) AND CLINICAL BLEEDING IN UREMIA, Journal of the American Society of Nephrology, 5(3), 1994, pp. 340-340

Authors: ROTH D SMITH RD SCHULMAN G STEINMAN TI HATCH FE RUDNICK MR SLOAND JA FREEDMAN BI WILLIAMS WW SHADUR CA BENZ RL TEEHAN BP REVICKI DA SAROKHAN BJ ABELS RI
Citation: D. Roth et al., EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS, American journal of kidney diseases, 24(5), 1994, pp. 777-784
Risultati: 1-9 |